New Hope for Latinas Afflicted with Lupus


The bad news: Latinas and other women of color are three times likelier to develop lupus, a debilitating immune system disease that attacks healthy cells and tissues all over the body. The good news: For the first time in 50 years, there is a drug to treat this painful condition.

The medication Benlysta was approved this week by the Food and Drug Administration (FDA), giving hope to the 1.5 million Americans affected by lupus.

The cause of lupus is unknown, but scientists believe that it is partly genetic. Meaning that relatives of people with the condition are more at risk of being diagnosed with it, as well.

The disease is hard to detect. Known as “the great imitator,” many of its symptoms (tiredness, swelling in joints, abnormal blood clotting, hair loss, mouth ulcers, fever, muscle pain, etc.) are often associated with other conditions, such as rheumatoid arthritis, blood disorders, diabetes and heart disease, so it’s important to be extra vigilant if you experience unexplained persistent symptoms.

The hope is that Benylsta will reduce these symptoms. And the Lupus Foundation of America is optimistic, hailing the medication as “the first step toward reaching our goal of developing an arsenal of new, safe, effective, and tolerable treatments.”

For more information on lupus and Benylsta, please visit

Share this 
About this author

Grace Bastidas, Deputy Editor

Born and raised in Queens, New York, where more languages are spoken than anywhere in the world, Grace Bastidas is Latina’s Deputy Editor. She oversees lifestyle content, including topics as diverse as career, health and relationships, and occasionally writes about her own experiences in The Good Life section. As a writer, Grace’s work has appeared in The New York TimesNew York magazine, The Wall Street Journal and Travel + Leisure. She is fluent in Spanish.

What We're Reading
Like this post? Contribute to the discussion!

Subscribe to our newsletter